3HP

DRUG3 trials

Sponsors

Ottawa Hospital Research Institute, Chang Gung Memorial Hospital, The Aurum Institute NPC

Conditions

3HPAdverse Reaction to DrugHIVTuberculosis

Phase 1

Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)

Active, not recruitingNCT05122767

The Aurum Institute NPCHIV, Tuberculosis

Start: 2023-05-24End: 2025-12-31Target: 92Updated: 2025-12-12

Phase 4

Taima TB: 3HP Study

CompletedNCT02689089

Ottawa Hospital Research InstituteTuberculosis

Start: 2016-11-28End: 2019-08-15Updated: 2020-03-24

Unknown Phase

Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment

Chang Gung Memorial Hospital3HP, Adverse Reaction to Drug

Start: 2018-04-19End: 2021-02-12Target: 500Updated: 2020-12-07

Related Papers

Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection

Frontiers in Microbiology2022-03-035 citations